BIOMAT Database Logo BIOMAT Database Logo

[Various immunological and immunomorphological changes in patients with breast cancer after interferon administration]. 1986

L N Mkrtchian, and A M Galstian, and T G Ovanesbekova, and Z R Ter-Pogosian, and V P Kuznetsov

The immunologic and immunomorphologic effect of native alpha-interferon eta phi-II Parenteral) in 12 patients with stage II breast cancer was studied. A preoperative course of interferon injected into tumor was found to induce local and general immunomodulating effect which suggested activation of cellular antitumor immunity.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D007957 Leukocyte Adherence Inhibition Test Test for cell-mediated antitumor immunity and related serum blocking factors based on the finding that leukocytes from cancer patients, but not from controls, when mixed in vitro with antigenic extracts of tumors of the same histological type, undergo a diminution in their normal adherence to glass surfaces. Sera from tumor-bearing patients block the LAI reaction of their own leukocytes or those of other patients with the same type of tumor. LAI Test,LAI Tests,Test, LAI,Tests, LAI
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012397 Rosette Formation The in vitro formation of clusters consisting of a cell (usually a lymphocyte) surrounded by antigenic cells or antigen-bearing particles (usually erythrocytes, which may or may not be coated with antibody or antibody and complement). The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells. Immunocytoadherence,Formation, Rosette,Formations, Rosette,Immunocytoadherences,Rosette Formations
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

L N Mkrtchian, and A M Galstian, and T G Ovanesbekova, and Z R Ter-Pogosian, and V P Kuznetsov
[Morphological and immunologic changes following intratumoral administration of alpha interferon in patients with breast cancer].
January 1986, Voprosy onkologii,
L N Mkrtchian, and A M Galstian, and T G Ovanesbekova, and Z R Ter-Pogosian, and V P Kuznetsov
[Immunomodulating effect of interferon after its intra-tumor administration in patients with breast cancer].
January 1988, Sovetskaia meditsina,
L N Mkrtchian, and A M Galstian, and T G Ovanesbekova, and Z R Ter-Pogosian, and V P Kuznetsov
Evaluation of biomarker changes after administration of various neoadjuvant chemotherapies in breast cancer.
January 2015, International journal of clinical and experimental pathology,
L N Mkrtchian, and A M Galstian, and T G Ovanesbekova, and Z R Ter-Pogosian, and V P Kuznetsov
[Immunomorphological changes in the tissue of breast cancer and regional lymph nodes after preoperative radioisotope teletherapy].
January 1974, Vrachebnoe delo,
L N Mkrtchian, and A M Galstian, and T G Ovanesbekova, and Z R Ter-Pogosian, and V P Kuznetsov
[Immunomorphological changes in the tumors and regional lymph nodes in breast cancer patients treated preoperatively with radioactive gold].
January 1974, Pediatriia akusherstvo i ginekologiia,
L N Mkrtchian, and A M Galstian, and T G Ovanesbekova, and Z R Ter-Pogosian, and V P Kuznetsov
[Immunomorphological changes in the palatine tonsils and the body's immunological reactivity in chronic tonsillitis patients].
January 1984, Vestnik otorinolaringologii,
L N Mkrtchian, and A M Galstian, and T G Ovanesbekova, and Z R Ter-Pogosian, and V P Kuznetsov
Immunomorphological Changes in the Olfactory Bulbs of Rats after Intranasal Administration of Rotenone.
December 2017, Bulletin of experimental biology and medicine,
L N Mkrtchian, and A M Galstian, and T G Ovanesbekova, and Z R Ter-Pogosian, and V P Kuznetsov
Immunological changes in human breast cancer.
January 1988, European journal of gynaecological oncology,
L N Mkrtchian, and A M Galstian, and T G Ovanesbekova, and Z R Ter-Pogosian, and V P Kuznetsov
Clinical and immunological study of beta interferon by intramuscular route in patients with metastatic breast cancer.
January 1982, Journal of interferon research,
L N Mkrtchian, and A M Galstian, and T G Ovanesbekova, and Z R Ter-Pogosian, and V P Kuznetsov
[Immunological changes in patients with colorectal cancer].
January 1984, Mikrobiyoloji bulteni,
Copied contents to your clipboard!